Related Experiment Videos
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
L Chin1, J Pomerantz, D Polsky
1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Abstract:
The familial melanoma gene (INK4a/MTS1/CDKN2) encodes potent tumor suppressor activity. Although mice null for the ink4a homolog develop a cancer-prone condition, a pathogenetic link to melanoma susceptibility has yet to be established. Here we report that mice with melanocyte-specific expression of activated H-rasG12V on an ink4a-deficient background develop spontaneous cutaneous melanomas after a short latency and with high penetrance. Consistent loss of the wild-type ink4a allele was observed in tumors arising in ink4a heterozygous transgenic mice. No homozygous deletion of the neighboring ink4b gene was detected. Moreover, as in human melanomas, the p53 gene remained in a wild-type configuration with no observed mutation or allelic loss. These results show that loss of ink4a and activation of Ras can cooperate to accelerate the development of melanoma and provide the first in vivo experimental evidence for a causal relationship between ink4a deficiency and the pathogenesis of melanoma. In addition, this mouse model affords a system in which to identify and analyze pathways involved in tumor progression against the backdrop of genetic alterations encountered in human melanomas.
Insights
Loss of the INK4a tumor suppressor gene and Ras activation cooperate to accelerate melanoma development. This study provides the first in vivo evidence linking INK4a deficiency to melanoma pathogenesis.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The INK4a/MTS1/CDKN2 gene encodes a tumor suppressor crucial for cell cycle regulation.
- While ink4a-deficient mice are cancer-prone, a direct link to melanoma susceptibility is not established.
- Melanoma pathogenesis involves genetic alterations, including those affecting tumor suppressor genes.
Purpose of the Study:
- To investigate the role of INK4a deficiency in melanoma development.
- To establish a mouse model for studying melanoma pathogenesis.
- To explore the cooperation between INK4a loss and Ras activation in melanoma.
Main Methods:
- Generated mice with melanocyte-specific expression of activated H-rasG12V on an ink4a-deficient background.
- Observed spontaneous cutaneous melanoma development.
- Analyzed genetic alterations in tumor tissues, including ink4a allele loss and p53 gene status.
Main Results:
- Mice developed spontaneous cutaneous melanomas with high penetrance and short latency.
- Consistent loss of the wild-type ink4a allele was observed in tumors.
- The p53 gene remained wild-type, similar to human melanomas.
Conclusions:
- Loss of INK4a and Ras activation cooperate to accelerate melanoma development.
- This study provides the first in vivo experimental evidence for a causal link between ink4a deficiency and melanoma pathogenesis.
- The developed mouse model is valuable for studying melanoma progression and identifying therapeutic targets.